These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 2635839)

  • 1. [An activated charcoal filter for eliminating volatile anesthetics. A contribution to the management of malignant hyperthermia].
    Jantzen JP; Eck J; Kleemann PP
    Anaesthesist; 1989 Nov; 38(11):639-41. PubMed ID: 2635839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation of the Dräger Fabius anesthesia machine for the malignant-hyperthermia susceptible patient.
    Gunter JB; Ball J; Than-Win S
    Anesth Analg; 2008 Dec; 107(6):1936-45. PubMed ID: 19020141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated charcoal effectively removes inhaled anesthetics from modern anesthesia machines.
    Birgenheier N; Stoker R; Westenskow D; Orr J
    Anesth Analg; 2011 Jun; 112(6):1363-70. PubMed ID: 21543783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual volatile anesthetics after workstation preparation and activated charcoal filtration.
    Müller-Wirtz LM; Godsch C; Sessler DI; Volk T; Kreuer S; Hüppe T
    Acta Anaesthesiol Scand; 2020 Jul; 64(6):759-765. PubMed ID: 32153012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of modern anesthesia workstations for malignant hyperthermia-susceptible patients: a review of past and present practice.
    Kim TW; Nemergut ME
    Anesthesiology; 2011 Jan; 114(1):205-12. PubMed ID: 21169802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of contamination with a heat-and-moisture-exchanger (HME) and bacterial filter during clinical anesthesia].
    Shibata M; Asano M
    Masui; 1998 Dec; 47(12):1464-70. PubMed ID: 9990215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation of the Dräger Primus anesthetic machine for malignant hyperthermia-susceptible patients.
    Prinzhausen H; Crawford MW; O'Rourke J; Petroz GC
    Can J Anaesth; 2006 Sep; 53(9):885-90. PubMed ID: 16960266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Malignant Hyperthermia Association of the United States-Recommended Methods of Preparation for Malignant Hyperthermia-Susceptible Patients Using Dräger Zeus Anesthesia Workstations and Associated Costs.
    Neira VM; Al Madhoun W; Ghaffari K; Barrowman N; Berrigan P; Splinter W
    Anesth Analg; 2019 Jul; 129(1):74-83. PubMed ID: 29847377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of modern anesthesia workstations for malignant hyperthermia-susceptible patients: when are they really clean?
    Wappler F
    Anesthesiology; 2011 Aug; 115(2):434-5; author reply 436-7. PubMed ID: 21791992
    [No Abstract]   [Full Text] [Related]  

  • 10. Preparation of Dräger Atlan A350 and General Electric Healthcare Carestation 650 anesthesia workstations for malignant hyperthermia susceptible patients.
    Heiderich S; Thoben C; Dennhardt N; Krauß T; Sümpelmann R; Zimmermann S; Reitz M; Rüffert H
    BMC Anesthesiol; 2021 Dec; 21(1):315. PubMed ID: 34903173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation of the Drager Fabius CE and Drager Zeus anaesthetic machines for patients susceptible to malignant hyperthermia.
    Shanahan H; O'Donoghue R; O'Kelly P; Synnott A; O'Rourke J
    Eur J Anaesthesiol; 2012 May; 29(5):229-34. PubMed ID: 22388705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of anaesthesia workstation for trigger-free anaesthesia: An observational laboratory study.
    Thoben C; Dennhardt N; Krauß T; Sümpelmann R; Zimmermann S; Rüffert H; Heiderich S
    Eur J Anaesthesiol; 2019 Nov; 36(11):851-856. PubMed ID: 31580288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clarifying the role of activated charcoal filters in preparing an anaesthetic workstation for malignant hyperthermia-susceptible patients.
    Bilmen JG; Gillies RI
    Anaesth Intensive Care; 2014 Jan; 42(1):51-8. PubMed ID: 24471664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation of the Dräger Fabius GS workstation for malignant hyperthermia-susceptible patients.
    Whitty RJ; Wong GK; Petroz GC; Pehora C; Crawford MW
    Can J Anaesth; 2009 Jul; 56(7):497-501. PubMed ID: 19399571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant hyperthermia: removal of volatile anesthetic agents from the breathing circuit using activated charcoal.
    Greene ER
    Anesthesiology; 1986 Aug; 65(2):240-1. PubMed ID: 3740531
    [No Abstract]   [Full Text] [Related]  

  • 16. Anesthesia for patients with a history of malignant hyperthermia.
    Wappler F
    Curr Opin Anaesthesiol; 2010 Jun; 23(3):417-22. PubMed ID: 20173632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comments on the paper by J.-P. Jantzen et al. An active charcoal filter for removing volatile anesthetics].
    Goerig M
    Anaesthesist; 1990 Dec; 39(12):637-9. PubMed ID: 2073047
    [No Abstract]   [Full Text] [Related]  

  • 18. Activated charcoal adsorption of volatile anesthetic agents for anesthesia machine preparation of malignant hyperthermia susceptible patients.
    Martin JW; Welliver MD
    AANA J; 2013 Jun; 81(3):169-71. PubMed ID: 23923663
    [No Abstract]   [Full Text] [Related]  

  • 19. Ambulatory surgery and malignant hyperthermia.
    Brandom BW
    Curr Opin Anaesthesiol; 2009 Dec; 22(6):744-7. PubMed ID: 19812484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Charcoal as an airway isoflurane reflection filter.
    Dahm SL; Steptoe P; Luttropp HH; Reinstrup P
    Eur J Anaesthesiol; 1998 Mar; 15(2):230-3. PubMed ID: 9587731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.